Cybin Inc share price logo

Cybin Inc Share Price

NASDAQ: HELP

Small Cap

$7.33

-0.42

(-5.48%)

as on

Cybin Inc Stock Performance

as on February 28, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $7.23
    $7.76
    downward going graph

    1.36%

    Downside

    5.87%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Cybin Inc share price movements today

Previous Close
$7.76
Open
$7.60
Volume
734.4K
Day's Low - High
$7.23 - $7.76

Cybin Inc Historical Returns

1 Month Return
+ 3.09 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Cybin Inc Stock Fundamentals & Key Indicators

Check Cybin Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$387.2M

EPS (TTM)

-5.1587

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-55.89%

Cybin Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cybin Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Cybin Inc image
Cybin Inc
NA$387.2MNANA0.00%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$122.0B133.75%31.3432.94%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$43.9B124.79%142.788.45%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$35.7BNA619.941.38%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$81.5B73.48%18.5931.41%

Cybin Inc Stock’s Investor Sentiment and Interest

Search interest for Cybin Inc Stock has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-57% versus previous 30 day period

Cybin Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
0
0
-
0
0
0
Operating Income
-57
-32
-33
-33
-40
-56
EBITDA
-57
-32
-
-33
-40
-56
Interest Expense
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
Income Before Tax
-56
-10
-30
-33
-47
-58
Income Tax Expense
-
-
-
-
-
-
Net Income
-56
-7
-21
-33
-47
-58
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Cybin Inc Annual Profit & Loss

All numbers in Millions USD

Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Total Revenue
0
-
-
-
-
Gross Profit
0
0
0
0
0
Operating Income
-31
-63
-51
-78
-143
EBITDA
-30
-63
-51
-78
-142
Interest Expense
0
0
-
-
-
Depreciation
-
0
0
0
0
Income Before Tax
-32
-67
-47
-78
-113
Income Tax Expense
-
-
-
-
-
Net Income
-32
-53
-34
-57
-78
Net Profit Margin
-3729.17%
0.00%
0.00%
0.00%
0.00%

Cybin Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-30
-21
-10
-56
-10
-50
-24
-47
-58
Operating Cash Flow
-26
-20
-19
-25
-26
-21
-29
-48
-43
Investing Cash Flow
7
0
0
0
0
-
0
0
0
Financing Cash Flow
39
190
0
0
0
20
54
0
197
Change in Cash
20
169
-20
-26
-28
-1
24
-48
152

Cybin Inc Annual Cash Flow

All numbers in Millions USD

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Income
0
0
0
-32
-67
-47
-78
-113
Operating Cash Flow
0
0
0
-19
-45
-47
-68
-101
Investing Cash Flow
0
0
0
-1
0
-3
6
-1
Financing Cash Flow
0
-
0
82
35
13
254
20
Change in Cash
0
0
0
62
-10
-37
192
-73

Insights on Cybin Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, HELP stock has moved up by 7.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 34.9% return, outperforming this stock by 44.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 70.4% return, outperforming this stock by 129.7%

About Cybin Inc

Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II. It has an intellectual property portfolio in the psychedelic drug development sector with over 30 patents granted and 160 patents pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands and Ireland.
OrganisationCybin Inc
Headquarters100 King Street West, Toronto, ON, Canada, M5X 1C9
CEOMr. Michael F. Cola
E-voting on sharesClick here to vote

Key Management of Cybin Inc

Name

Title

Mr. Gabriel Fahel

Chief Legal Officer & Corporate Secretary

Mr. Michael F. Cola

Chief Executive Officer

Mr. Aaron Bartlone

Chief Operating Officer

Dr. Alex L. Nivorozhkin Ph.D.

Chief Scientific Officer

Mr. Eric So L.L.B.

Co-Founder, President & Executive Chairman

Mr. Paul Glavine

Co-Founder, Chief Growth Officer & Director

Mr. Greg Cavers

Chief Financial Officer

Mr. George Tziras

Chief Business Officer

Mr. John Kanakis

Co-Founder

Ms. Lori Challenger

Chief Compliance, Ethics & Administrative Officer

FAQs

What is Cybin Inc share price today?

Cybin Inc share price today is $7.33 as on at the close of the market. Cybin Inc share today touched a day high of $7.76 and a low of $7.23.

What is the 52 week high and 52 week low for Cybin Inc share?

Cybin Inc share touched a 52 week high of $ on and a 52 week low of $ on . Cybin Inc stock price today i.e. is closed at $7.33,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Cybin Inc's market capitalisation today?

Cybin Inc market capitalisation is $0.00T as on .

How to invest in Cybin Inc Stock (HELP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cybin Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cybin Inc Shares that will get you 0.2046 shares as per Cybin Inc share price of $7.33 per share as on February 28, 2026 at 2:29 am IST.

What is the minimum amount required to buy Cybin Inc Stock (HELP) from India?

Indian investors can start investing in Cybin Inc (HELP) shares with as little as ₹91.026 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹910.26 in Cybin Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Cybin Inc share’s latest price of $7.33 as on February 28, 2026 at 2:29 am IST, you will get 1.3643 shares of Cybin Inc. Learn more about fractional shares .